1 Munoz-Garrido P, "Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease" 63 : 952-961, 2015
2 Camilleri M, "Therapeutic targeting of bile acids" 309 : G209-G215, 2015
3 Schaffner CA, "The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes" 35 : 1152-1161, 2015
4 Dawson PA, "Role of the intestinal bile acid transporters in bile acid and drug disposition" 201 : 169-203, 2011
5 Cheng L, "Role of cholangiocyte bile Acid transporters in large bile duct injury after rat liver transplantation" 90 : 127-134, 2010
6 Chothe PP, "Resveratrol promotes degradation of the human bile acid transporter ASBT(SLC10A2)" 459 : 301-312, 2014
7 Hall C, "Regulators of cholangiocyte proliferation" 17 : 155-171, 2017
8 Alvaro D, "Regulation and deregulation of cholangiocyte proliferation" 33 : 333-340, 2000
9 Han Y, "Recent advances in the morphological and functional heterogeneity of the biliary epithelium" 238 : 549-565, 2013
10 Glaser SS, "Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium" 89 : 456-469, 2009
1 Munoz-Garrido P, "Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease" 63 : 952-961, 2015
2 Camilleri M, "Therapeutic targeting of bile acids" 309 : G209-G215, 2015
3 Schaffner CA, "The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes" 35 : 1152-1161, 2015
4 Dawson PA, "Role of the intestinal bile acid transporters in bile acid and drug disposition" 201 : 169-203, 2011
5 Cheng L, "Role of cholangiocyte bile Acid transporters in large bile duct injury after rat liver transplantation" 90 : 127-134, 2010
6 Chothe PP, "Resveratrol promotes degradation of the human bile acid transporter ASBT(SLC10A2)" 459 : 301-312, 2014
7 Hall C, "Regulators of cholangiocyte proliferation" 17 : 155-171, 2017
8 Alvaro D, "Regulation and deregulation of cholangiocyte proliferation" 33 : 333-340, 2000
9 Han Y, "Recent advances in the morphological and functional heterogeneity of the biliary epithelium" 238 : 549-565, 2013
10 Glaser SS, "Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium" 89 : 456-469, 2009
11 Ferrebee CB, "Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids" 5 : 129-134, 2015
12 Hofmann AF, "Key discoveries in bile acid chemistry and biology and their clinical applications : history of the last eight decades" 55 : 1553-1595, 2014
13 Priester S, "Involvement of cholangiocyte proliferation in biliary fibrosis" 1 : 30-37, 2010
14 Sawada R, "Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas" 73 : 259-272, 2018
15 Song P, "Individual bile acids have differential effects on bile acid signaling in mice" 283 : 57-64, 2015
16 Maroni L, "Functional and structural features of cholangiocytes in health and disease" 1 : 368-380, 2015
17 Jung D, "FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway" 466 : 1011-1019, 2014
18 Lozano E, "Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development" 12 : 91-100, 2014
19 Masyuk AI, "Cholangiocyte primary cilia in liver health and disease" 237 : 2007-2012, 2008
20 Marin JJ, "Bile acids in physiology, pathology and pharmacology" 17 : 4-29, 2015
21 Alrefai WA, "Bile acid transporters : structure, function, regulation and pathophysiological implications" 24 : 1803-1823, 2007
22 Xia X, "Bile acid interactions with cholangiocytes" 12 : 3553-3563, 2006
23 Alpini G, "Activation of alpha(1)-adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1" 53 : 628-639, 2011
24 Benedetti A, "A morphometric study of the epithelium lining the rat intrahepatic biliary tree" 24 : 335-342, 1996